Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT06559241Phase 3Recruiting
Phase 3, randomised, single-blind trial in ischemic stroke and Anterior circulation brain infarction (ACI) (3 arms), sponsored by Capital Medical University. Primary endpoint: Proportion of patients achieving a modified Rankin Scale score of 0-2 at 90 days. Started Sep 2024; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT06559241.